Sunshine Biopharma Inc.

SBFM Nasdaq SEC CIK 1402328
Follow Sunshine Biopharma Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $9.4M +0.3% vs same quarter last year
Net income −$1.2M −38.5% vs same quarter last year
EPS, diluted -
Operating cash flow −$1.4M −85.3% vs same quarter last year
Revenue by quarter
$9.6M
$8.9M
$9.4M
$9.4M
$8.6M
$8.1M
$9.3M
$9.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20M$40MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$36.3M−$6M
FY24$34.9M−$5.1M
FY23$24.1M−$4.5M
FY22$4.3M−$26.7M
FY21$228.4K−$12.4M
FY20$71.4K−$2.8M
FY19$21.1K−$1.7M
FY18$0−$2.2M
FY17$0−$1M
FY16$0−$3.5M
FY15$1.7K−$1.7M
FY14$0−$1.9M
FY13$0−$2.5M
FY12$0−$708K
FY11$0−$556.2K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100000%−75000%−50000%−25000%0%25000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2533.8%−17.2%−16.5%
FY2430.6%−16.7%−14.7%
FY2334.6%−19.9%−18.7%
FY2239%−621.3%−615.4%
FY2148.4%−1068.2%−5444.4%
FY2063.8%−807.8%−3898.7%
FY1947.7%−3037.9%−7860.9%
FY18---
FY17---
FY16---
FY15-−45683.7%−96774.5%
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$5.5M
FY24−$14.2M
FY23−$8.9M
FY22−$5.4M
FY21−$1.8M
FY20−$658.5K
FY19−$496.7K
FY18−$531.7K
FY17−$547.2K
FY16−$317.6K
FY15−$872.4K
FY14−$538.6K
FY13-
FY12-
FY11-
Returned to shareholdersDividends paid and shares bought back
$0$1M$2M$3M$4MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$0
FY24$3.1M
FY23$541.1K
FY22-
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sunshine Biopharma
  • Healthcare median
−100000%−75000%−50000%−25000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearSunshine BiopharmaHealthcare median
FY25−16.5%−30.6%
FY24−14.7%−47%
FY23−18.7%−58%
FY22−615.4%−80.4%
FY21−5444.4%−71.8%
FY20−3898.7%−62.2%
FY19−7860.9%−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15−96774.5%−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%